The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nationwide implementation of best practices in pancreatic cancer care (PACAP-1): Stepped-wedge cluster randomized trial.
 
Tara Mackay
No Relationships to Disclose
 
Anouk EJ Latenstein
No Relationships to Disclose
 
Simone Augustinus
No Relationships to Disclose
 
Lydia G. van der Geest
No Relationships to Disclose
 
Auke Bogte
No Relationships to Disclose
 
Bert A. Bonsing
No Relationships to Disclose
 
Hendrik Bos
No Relationships to Disclose
 
Koop Bosscha
No Relationships to Disclose
 
Lodewijk Brosens
No Relationships to Disclose
 
Geert A. Cirkel
No Relationships to Disclose
 
Lieke Hol
No Relationships to Disclose
 
Olivier R.C. Busch
No Relationships to Disclose
 
Geert-Jan Creemers
No Relationships to Disclose
 
Wouter L. Curvers
No Relationships to Disclose
 
Sarah Derks
No Relationships to Disclose
 
Jeanin E. van Hooft
Consulting or Advisory Role - Abbvie; Boston Scientific; Cook Medical; Medtronic; Olympus Medical Systems
 
Casper H.J. Van Eijck
No Relationships to Disclose
 
Johanna Wilmink
Consulting or Advisory Role - Celgene; Merck; SERVIER
Speakers' Bureau - Medscape
Research Funding - AstraZeneca (Inst); Celgene; Merck (Inst); Novartis; Pfizer/EMD Serono (Inst); Roche (Inst); SERVIER
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Amphera (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Daiichi (Inst); Dragonfly Therapeutics (Inst); Merck (Inst); Novartis (Inst); Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen-Cilag (Inst); Merck KGaA (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Marc G. Besselink
No Relationships to Disclose